<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Cdxdiagnostics - Latest News</title>
<link href="https://news.newswirebiz.com/rss/cdxdiagnostics/latest.xml"></link>
<updated>2026-07-19T20:41:59+00:00</updated>
<id>urn:uuid:95d88810-42d9-0b4a-0b92-17095db327ac</id>
<entry>
<title>CDx Diagnostics to Present WATS3D Progression Data at DDW 2025</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/cdx-diagnostics-to-present-wats3d-progression-data-at-ddw-2025-8ofhnr5qn2fc"></link>
<id>urn:uuid:64b26a39-f4d0-6235-fae6-4c471ee9984d</id>
<summary type="html"><![CDATA[The WATS3D test for Barrett's esophagus and dysplasia screening and surveillance has been selected for podium presentation at the 2025 Digestive Disease Week (DDW) in San Diego, the premier conference for gastroenterology professionals.]]></summary>
<updated>2025-06-24T12:17:22+00:00</updated>
</entry>
<entry>
<title>400,000 WATS3D Procedures Marks Significant Milestone In Advancing Patient Care &amp; Saving Lives</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/400-000-wats3d-procedures-marks-significant-milestone-in-advancing-patient-care-saving-lives-tk01dlu20bgd"></link>
<id>urn:uuid:a2ddfda1-78e7-9611-e683-719e35fe496d</id>
<summary type="html"><![CDATA[WATS3D, the company’s proprietary diagnostic platform leverages AI enabled tissue analysis and 3D imaging to identify precancerous cells in the esophagus]]></summary>
<updated>2025-05-13T07:21:29+00:00</updated>
</entry>
<entry>
<title>Paving the Way for Early Esophageal Cancer Detection</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/paving-the-way-for-early-esophageal-cancer-detection-e7utcnlv9y8r"></link>
<id>urn:uuid:88319a6c-9fd4-9306-1753-0b7f757d68c6</id>
<summary type="html"><![CDATA[WATS3D  enhances traditional forceps biopsy testing with an innovative brush sampling technique and AI assisted 3D imaging to detect abnormal cells that might otherwise go undetected.]]></summary>
<updated>2025-04-18T04:46:46+00:00</updated>
</entry>
<entry>
<title>WATS3D Significantly Boosts Barrett&#039;s Esophagus and Dysplasia Detection Rates in Landmark Clinical Study</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/wats3d-significantly-boosts-barretts-esophagus-and-dysplasia-detection-rates-in-landmark-clinical-study-7rjbaaflp0ru"></link>
<id>urn:uuid:aa39c770-1904-3678-88a1-ec26530605fc</id>
<summary type="html"><![CDATA[The pivotal study highlighted WATS3D's significant impact on improving precancer detection during GERD screenings.]]></summary>
<updated>2025-03-12T10:41:29+00:00</updated>
</entry>
<entry>
<title>WATS3D Solution: Barretts and Esophageal Cancer Early Detection Test</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/wats3d-solution-barretts-and-esophageal-cancer-early-detection-test-b3jos4jbc535"></link>
<id>urn:uuid:9624da27-1da4-ec26-c5c8-d448d41510be</id>
<summary type="html"><![CDATA[CDx Diagnostics, Inc., developer and provider of the WATS3D solution, today announces a substantial expansion in its insurance coverage network]]></summary>
<updated>2025-02-26T06:36:38+00:00</updated>
</entry>
<entry>
<title>PIONEER IN THE USE OF AI IN THE DETECTION OF DYSPLASTIC CELLS IS PAVING THE FUTURE OF DIAGNOSTICS</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/pioneer-in-the-use-of-ai-in-the-detection-of-dysplastic-cells-is-paving-the-future-of-diagnostics-p2kwfnha7si0"></link>
<id>urn:uuid:bfec64f6-26be-3b51-bfdd-67a337d15557</id>
<summary type="html"><![CDATA[CDx Diagnostics, Inc. today announced that it has received its 400,000th WATS3D specimen. WATS3D, the company’s proprietary diagnostic platform leverages AI enabled tissue analysis and 3D imaging to identify precancerous cells in the esophagus.]]></summary>
<updated>2025-01-29T12:18:18+00:00</updated>
</entry>
<entry>
<title>Advancing Precision in Barrett&#039;s Esophagus and Dysplasia Diagnoses: WATS3D Study Demonstrates Exceptional Consensus Among Pathologists</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/advancing-precision-in-barretts-esophagus-and-dysplasia-diagnoses-wats3d-study-demonstrates-exceptional-consensus-among-pathologists-qobqdif57bat"></link>
<id>urn:uuid:a884f3f8-3d6b-0587-a422-3919d35f37b9</id>
<summary type="html"><![CDATA[Our findings show a high level of accuracy and reproducibility among GI pathologists who have had no prior experience with the WATS3D platform,” stated Dr. Robert Odze]]></summary>
<updated>2024-12-23T11:10:10+00:00</updated>
</entry>
<entry>
<title>WATS3D Significantly Boosts Barrett&#039;s Esophagus and Dysplasia Detection Rates in Landmark Clinical Study</title>
<link href="https://news.newswirebiz.com/@cdxdiagnostics/wats3d-significantly-boosts-barretts-esophagus-and-dysplasia-detection-rates-in-landmark-clinical-study-88dj4w4rg3os"></link>
<id>urn:uuid:549926f3-4d15-7457-5409-e3a5804616fa</id>
<summary type="html"><![CDATA[CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and surveillance of Barrett's esophagus (BE) and dysplasia, today announced the publication of a new study.]]></summary>
<updated>2024-11-14T11:13:58+00:00</updated>
</entry>
</feed>